F. Y. Chang

An Asia-Pacific, double blind, placebo controlled, randomised study to evaluate the efficacy, safety, and tolerability of tegaserod in patients with irritable bowel syndrome

John Kellow, O. Y. Lee, F. Y. Chang et al. · Gut · 2003 · 231 citations

Medicine, Pharmacology, Pharmacotherapy +13

Methicillin-Resistant Staphylococcus aureus: The Other Emerging Resistant Gram-Positive Coccus among Liver Transplant Recipients

N. Singh, David L. Paterson, F. Y. Chang et al. · Clinical Infectious Diseases · 2000 · 149 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Prognostic Value of Plasma Endotoxin Levels in Patients with Cirrhosis

CHO‐YU CHAN, Shinn‐Jang Hwang, F. Y. Lee et al. · Scandinavian Journal of Gastroenterology · 1997 · 113 citations

Medicine, Pathobiology, Hepatology +16

Neuronal correlates of gastric pain induced by fundus distension: a 3T‐fMRI study

Ching‐Liang Lu, Yu‐Tzu Wu, Tzu-Cheng Yeh et al. · Neurogastroenterology & Motility · 2004 · 105 citations

Medicine, Neurobiology, Neuroscience +17

Patients with nonalcoholic fatty liver disease have higher risk of colorectal adenoma after negative baseline colonoscopy

Kai-hong Huang, Hsin‐Bang Leu, Yan‐Jiang Wang et al. · Colorectal Disease · 2013 · 85 citations

Medicine, Oncology, Epidemiology +15